Assessment of Amprenavir plasma Cmin levels in patients receiving once-daily fos-amprenavir in combination with either 100 or 200 mg ritonavir

被引：0
|
作者：
Muret, P.
Muret, P.
Montange, D.
Bettinger, D.
Faller, J. P.
Beck-Wirth, G.
Martha, B.
Hoen, B.
机构：
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2007年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
216
引用
收藏
页码：44 / 44
页数：1
相关论文
共 27 条
  • [21] Once-daily (OD) maraviroc (MVC) in combination with ritonavir (/r)-boosted darunavir (DRV) (800/100mg): 300mg or 150mg: a little too much or a little too little?
    Okoli, C.
    William, S.
    Dufty, N.
    Hickinbottom, G.
    Gilleran, G.
    Schulz, K.
    Ghandi, K.
    Ainsworth, J.
    Watson, J.
    Smit, E.
    Taylor, S.
    HIV MEDICINE, 2011, 12 : 75 - 75
  • [22] Efficacy of once-daily darunavir/ritonavir 800/100 mg in HIV-infected, treatment-experienced patients with no baseline resistance-associated mutations to darunavir
    De Meyer, Sandra M. J.
    Spinosa-Guzman, Sabrina
    Vangeneugden, Tony J.
    de Bethune, Marie-Pierre
    Miralles, G. Diego
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 49 (02) : 179 - 182
  • [23] Pharmacokinetics, efficacy, and safety of darunavir/ritonavir 800/100 mg once-daily in treatment-naive and -experienced patients. (vol 9, pg 418, 2009)
    Bofitto, M.
    HIV CLINICAL TRIALS, 2009, 10 (02): : VI - VI
  • [24] Switching to darunavir/ritonavir 800/100?mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1
    Ghosn, Jade
    Slama, Laurence
    Chermak, Aziza
    Houssaini, Allal
    Lambert-Niclot, Sidonie
    Schneider, Luminita
    Fourn, Erwan
    Duvivier, Claudine
    Simon, Anne
    Courbon, Eve
    Murphy, Robert
    Flandre, Philippe
    Peytavin, Gilles
    Katlama, Christine
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (01) : 8 - 15
  • [25] RANDOMIZED, DOUBLE-BLIND, 3-WAY CROSS-OVER STUDY OF DILEVALOL 200 AND 400 MG AND ATENOLOL 100 MG ONCE-DAILY IN PATIENTS WITH CHRONIC STABLE ANGINA-PECTORIS
    BOWLES, MJ
    SMITH, L
    GLOVER, DR
    JOURNAL OF HUMAN HYPERTENSION, 1990, 4 : 85 - 90
  • [26] Saquinavir/Atazanavir/Ritonavir 2000/300/100 mg given once daily and optimized through early therapeutic drug monitoring provides adequate plasma drug concentrations and is virologically effective in patients failing
    Muret, P.
    Foltzer, A.
    Montange, D.
    Beck-Wirth, G.
    Martha, B.
    Batard, M. L.
    Letranchant, L.
    Rey, D.
    Berger, J. L.
    Drobacheff, C.
    Hoen, B.
    Kantelip, J. P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 87 - 88
  • [27] Clinical and pharmacokinetic data support once-daily low-dose boosted saquinavir (1,200 milligrams saquinavir with 100 milligrams ritonavir) in treatment-naive or limited protease inhibitor-experienced human immunodeficiency virus-infected patients
    Marin-Niebla, Ana
    Lopez-Cortes, Luis Fernando
    Ruiz-Valderas, Rosa
    Viciana, Pompeyo
    Mata, Rosario
    Gutierrez, Alicia
    Pascual, Rosario
    Rodriguez, Magdalena
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) : 2035 - 2042
123